212 related articles for article (PubMed ID: 16332232)
1. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects.
Han DK; Kim CS; Jung UW; Chai JK; Choi SH; Kim CK; Cho KS
J Periodontol; 2005 Dec; 76(12):2216-22. PubMed ID: 16332232
[TBL] [Abstract][Full Text] [Related]
2. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.
Ahn SH; Kim CS; Suk HJ; Lee YJ; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
J Periodontol; 2003 Jun; 74(6):787-97. PubMed ID: 12886988
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
[TBL] [Abstract][Full Text] [Related]
6. The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects.
Jung UW; Choi SY; Pang EK; Kim CS; Choi SH; Cho KS
J Periodontol; 2006 May; 77(5):765-72. PubMed ID: 16671867
[TBL] [Abstract][Full Text] [Related]
7. Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model.
Pelaez M; Susin C; Lee J; Fiorini T; Bisch FC; Dixon DR; McPherson JC; Buxton AN; Wikesjö UM
J Clin Periodontol; 2014 Aug; 41(8):827-36. PubMed ID: 24807100
[TBL] [Abstract][Full Text] [Related]
8. Growth factors and bone regeneration. Implications of barrier membranes.
Zellin G
Swed Dent J Suppl; 1998; 129():7-65. PubMed ID: 9672999
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of bone formation induced by human demineralized freeze-dried bone and enamel matrix derivative in rat calvaria critical-size bone defects.
Intini G; Andreana S; Buhite RJ; Bobek LA
J Periodontol; 2008 Jul; 79(7):1217-24. PubMed ID: 18597604
[TBL] [Abstract][Full Text] [Related]
10. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
11. Effect of platelet-rich plasma and fibrin glue on healing of critical-size calvarial bone defects.
Findikcioglu K; Findikcioglu F; Yavuzer R; Elmas C; Atabay K
J Craniofac Surg; 2009 Jan; 20(1):34-40. PubMed ID: 19164985
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel alloplast for osseous regeneration in the rat calvarial model.
Francis PO; McPherson JC; Cuenin MF; Hokett SD; Peacock ME; Billman MA; Sharawy M
J Periodontol; 2003 Jul; 74(7):1023-31. PubMed ID: 12931765
[TBL] [Abstract][Full Text] [Related]
14. Effect of bone morphogenetic protein-2, demineralized bone matrix and systemic parathyroid hormone (1-34) on local bone formation in a rat calvaria critical-size defect model.
Stancoven BW; Lee J; Dixon DR; McPherson JC; Bisch FC; Wikesjö UM; Susin C
J Periodontal Res; 2013 Apr; 48(2):243-51. PubMed ID: 22970744
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2.
Jung RE; Schmoekel HG; Zwahlen R; Kokovic V; Hammerle CH; Weber FE
Clin Oral Implants Res; 2005 Dec; 16(6):676-82. PubMed ID: 16307574
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bone augmentation by controlled release of recombinant human bone morphogenetic protein-2 from bioabsorbable membranes.
Lee YM; Nam SH; Seol YJ; Kim TI; Lee SJ; Ku Y; Rhyu IC; Chung CP; Han SB; Choi SM
J Periodontol; 2003 Jun; 74(6):865-72. PubMed ID: 12886998
[TBL] [Abstract][Full Text] [Related]
17. Guided bone regeneration using rhGDF-5- and rhBMP-2-coated natural bone mineral in rat calvarial defects.
Schwarz F; Ferrari D; Sager M; Herten M; Hartig B; Becker J
Clin Oral Implants Res; 2009 Nov; 20(11):1219-30. PubMed ID: 19719740
[TBL] [Abstract][Full Text] [Related]
18. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling.
Higuchi T; Kinoshita A; Takahashi K; Oda S; Ishikawa I
J Periodontol; 1999 Sep; 70(9):1026-31. PubMed ID: 10505805
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys.
Hanisch O; Sorensen RG; Kinoshita A; Spiekermann H; Wozney JM; Wikesjö UM
J Periodontol; 2003 May; 74(5):648-57. PubMed ID: 12816297
[TBL] [Abstract][Full Text] [Related]
20. Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model.
Bateman JP; Safadi FF; Susin C; Wikesjö UM
J Periodontal Res; 2012 Apr; 47(2):243-7. PubMed ID: 22097911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
